Latest News about Analyst Color
Recent news which mentions Analyst Color
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
November 11, 2024
From Benzinga
Tesla Remains Core For Gary Black Despite Price Cuts, Earnings Drop — Nvidia, Google, Eli Lilly Among Top Performers In Tech Bull's Portfolio
November 10, 2024
From Benzinga
From Benzinga
SolarEdge Is A 'Show-Me Story' After Disappointing Q3: Analyst
November 08, 2024
From Benzinga
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
November 08, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside
November 08, 2024
From Benzinga
Lucid's Delivery Gains, New SUV Can't Shake Profit Concerns
November 08, 2024
From Benzinga
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
November 08, 2024
From Benzinga
Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
November 08, 2024
From Benzinga
Wingstop's Strong Unit Economics - Goldman Sachs Upgrades Stock
November 08, 2024
From Benzinga
Penn Entertainment Analysts Say 'All Eyes Remain On ESPN Bet' After Q3 Earnings Miss
November 08, 2024
From Benzinga
Upstart's Enhanced Lending Model Drives Revenue Growth, Analyst Sees Further Upside Potential
November 08, 2024
From Benzinga
From Benzinga
Pinterest Reports Healthy Q3, Q4 Guidance Disappoints: 6 Analysts Cut Forecasts — Will AI Tools 'Start To Help' In 2025?
November 08, 2024
Tickers
PINS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.